全文获取类型
收费全文 | 686篇 |
免费 | 72篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 9篇 |
妇产科学 | 20篇 |
基础医学 | 101篇 |
口腔科学 | 19篇 |
临床医学 | 56篇 |
内科学 | 238篇 |
皮肤病学 | 7篇 |
神经病学 | 34篇 |
特种医学 | 17篇 |
外科学 | 108篇 |
综合类 | 5篇 |
预防医学 | 30篇 |
眼科学 | 11篇 |
药学 | 38篇 |
肿瘤学 | 61篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 7篇 |
2020年 | 9篇 |
2019年 | 13篇 |
2018年 | 16篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 21篇 |
2014年 | 16篇 |
2013年 | 24篇 |
2012年 | 46篇 |
2011年 | 39篇 |
2010年 | 22篇 |
2009年 | 22篇 |
2008年 | 33篇 |
2007年 | 40篇 |
2006年 | 52篇 |
2005年 | 42篇 |
2004年 | 39篇 |
2003年 | 45篇 |
2002年 | 30篇 |
2001年 | 14篇 |
2000年 | 14篇 |
1999年 | 14篇 |
1998年 | 12篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 8篇 |
1994年 | 9篇 |
1993年 | 11篇 |
1992年 | 7篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 9篇 |
1988年 | 9篇 |
1987年 | 5篇 |
1986年 | 16篇 |
1985年 | 8篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1968年 | 2篇 |
1956年 | 1篇 |
排序方式: 共有762条查询结果,搜索用时 15 毫秒
81.
Thompson M Ivaz S Cheshire N Fattori R Rousseau H Heijmen R Beregi JP Thony F Horne G Morgan R Loftus I 《Cardiovascular and interventional radiology》2007,30(6):1130-1138
Endovascular repair of the thoracic aorta has been adopted as the first-line therapy for much pathology. Initial results from
the early-generation endografts have highlighted the potential of this technique. Newer-generation endografts have now been
introduced into clinical practice and careful assessment of their performance should be mandatory. This study describes the
initial experience with the Valiant endograft and makes comparisons with similar series documenting previous-generation endografts.
Data were retrospectively collected on 180 patients treated with the Valiant endograft at seven European centers between March
2005 and October 2006. The patient cohort consisted of 66 patients with thoracic aneurysms, 22 with thoracoabdominal aneurysms,
19 with an acute aortic syndrome, 52 with aneurysmal degeneration of a chronic dissection, and 21 patients with traumatic
aortic transection. The overall 30-day mortality for the series was 7.2%, with a stroke rate of 3.8% and a paraplegia rate
of 3.3%. Subgroup analysis demonstrated that mortality differed significantly between different indications; thoracic aneurysms
(6.1%), thoracoabdominal aneurysms (27.3%), acute aortic syndrome (10.5%), chronic dissections (1.9%), and acute transections
(0%). Adjunctive surgical procedures were required in 63 patients, and 51% of patients had grafts deployed proximal to the
left subclavian artery. Comparison with a series of earlier-generation grafts demonstrated a significant increase in complexity
of procedure as assessed by graft implantation site, number of grafts and patient comorbidity. The data demonstrate acceptable
results for a new-generation endograft in series of patients with diverse thoracic aortic pathology. Comparison of clinical
outcomes between different endografts poses considerable challenges due to differing case complexity. 相似文献
82.
Bridoux V Kianifard B Moutel G Herve C Tuech JJ 《The lancet oncology》2011,12(7):621; author reply 621-621; author reply 622
83.
84.
Richand V Lafitte S Reant P Serri K Lafitte M Brette S Kerouani A Chalabi H Dos Santos P Douard H Roudaut R 《The American journal of cardiology》2007,100(1):128-132
Deformation analysis using 2-dimensional strain echocardiography can detect early systolic function abnormalities in patients with left ventricular hypertrophy. This study was designed to characterize global and regional myocardial deformation using 2-dimensional strain in professional soccer players (PSPs) compared with control subjects and patients with hypertrophic cardiomyopathy (HC). Twenty nine PSPs, 26 patients with HC, and 17 controls were investigated at rest using transthoracic echocardiography with 2-dimensional strain analysis. Radial and transverse strains were significantly higher in PSPs compared with controls, whereas longitudinal strain was lower. Compared with patients with HC, athletes had higher values for transverse, radial, and circumferential strains. In pathologic hypertrophic segments, longitudinal strain was lower in patients with HC than in PSPs. In conclusion, 2-dimensional strain can identify specific patterns of myocardial deformation in PSPs, controls, and patients with HC. It has the potential to become a routinely used method for the differentiation of athlete's heart and HC. 相似文献
85.
86.
Mouracade P Spie R Lang H Jacqmin D Saussine C 《Journal of endourology / Endourological Society》2008,22(2):273-275
PURPOSE: To evaluate the feasibility and safety of replacing the Double-J stent with a ureteral catheter in tubeless percutaneous nephrolithotomy (PCNL). MATERIALS AND METHODS: From August 1998 to February 2007, 33 patients underwent tubeless PCNL for renal calculi by the same surgeon. A retrograde 7F ureteral catheter was placed at the beginning of the surgery in all patients. A nephrostomy tube was not used in any patient. At the end of the procedure, the working tract was electrocauterized using a 26F resectoscope with a rollerball electrode; no hemostatic sealant was used. The ureteral catheter was the sole means of drainage left in place. The incidence and type of complications, the operative time, the length of hospitalization, the rate of transfusion, and the degree of pain were obtained by chart review. RESULTS: In this group of patients, the mean stone burden was 17.25 mm. The mean operative time was 71.5 min. The mean length of hospitalization was 1.9 day (range 1 to 7 days). The mean hemoglobin decrease was 0.8 g/dL. No blood transfusions were needed. The mean visual analog pain intensity scale was 1.87. Complications developed in five (15%) patients, of whom one needed a Double-J stent placement. The complications were pyelonephritis, urinary extravasation, sustained hematuria, and renal colic. The ureteral catheter was removed by postoperative day 1 in 91% of patients. CONCLUSIONS: Replacing the Double-J stent with a ureteral catheter in tubeless PCNL is an effective procedure and can be performed in patients with a moderate stone burden. The electrocauterization of the bleeding points at the end of percutaneous renal surgery with a rollerball resectoscope is safe. 相似文献
87.
Deborah Goldstein Nathan Ford Nicholas Kisyeri Maggie Munsamy Lirica Nishimoto Kufor Osi Herve Kambale Thomas Minior Moses Bateganya 《Journal of the International AIDS Society》2023,26(Z1):e26113
Introduction
Non-communicable diseases (NCDs) are highly prevalent in people living with HIV above 50 years of age and account for increasing mortality. There is little published evidence supporting person-centred, integrated models of HIV care, hypertension and diabetes treatment in southern Africa, and no data demonstrating mortality reduction. Where clinical visits for NCDs and HIV cannot be combined, integrated medication delivery presents an opportunity to streamline care and reduce patient costs. We present experiences of integrated HIV and NCD medication delivery in Eswatini and South Africa, focusing on programme successes and implementation challenges. Programmatic data from Eswatini's Community Health Commodities Distribution (CHCD) from April 2020 to December 2021 and South Africa's Central Chronic Medicines Dispensing and Distribution (CCMDD) from January 2016 to December 2021 were provided by programme managers and are summarized here.Discussion
Launched in 2020, Eswatini's CHCD provides over 28,000 people with and without HIV with integrated services, including HIV testing, CD4 cell count testing, antiretroviral therapy refills, viral load monitoring and pre-exposure prophylaxis alongside NCD services, including blood pressure and glucose monitoring and hypertension and diabetes medication refills. Communities designate neighbourhood care points and central gathering places for person-centred medication dispensing. This programme reported fewer missed medication refill appointments among clients in community settings compared to facility-based settings. South Africa's CCMDD utilizes decentralized drug distribution to provide medications for over 2.9 million people, including those living with HIV, hypertension and diabetes. CCMDD incorporates community-based pickup points, facility “fast lanes” and adherence clubs with public sector health facilities and private sector medication collection units. There are no out-of-pocket payments for medications or testing commodities. Wait-times for medication refills are lower at CCMDD sites than facility-based sites. Innovations to reduce stigma include uniformly labelled medication packages for NCD and HIV medications.Conclusions
Eswatini and South Africa demonstrate person-centred models for HIV and NCD integration through decentralized drug distribution. This approach adapts medication delivery to serve individual needs and decongest centralized health facilities while efficiently delivering NCD care. To bolster programme uptake, additional reporting of integrated decentralized drug distribution models should include HIV and NCD outcomes and mortality trends. 相似文献88.
Nick Verougstraete Annick Verhaeghe Jan Germonpré Herve Lebbinck Alain G. Verstraete 《Drug testing and analysis》2023,15(2):235-239
Etazene (or etodesnitazene) is a novel and highly active synthetic opioid belonging to the rapidly evolving and emerging group of “nitazenes.” Etazene metabolites were identified through analysis of a human urine sample. The sample was obtained from a 25-year-old man who attempted suicide by taking a new psychoactive substances (NPS) cocktail purchased online and was analyzed by ultrahigh performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS). Etazene metabolites were predicted with BioTransformer 3.0, and the exact masses were added to the inclusion list. Eight possible metabolites were identified in the urine sample. N- and O-deethylation were identified as the predominant metabolism routes, resulting in M1 (O-deethylated etazene; most abundant metabolite based on the peak area), M2 (N-deethylated etazene), and M3 (N,O-dideethylated etazene) metabolites. Less abundant hydroxylated products of these deethylated metabolites and etazene were also found. Additionally, in the analysis without β-glucuronidase treatment, M1- and M3-glucuronide phase II metabolites were found. As N- and O-deethylated products seem to be the predominant urinary metabolites, the detection of these metabolites in urine can be useful to demonstrate etazene exposure. 相似文献
89.
Ouguerram K Magot T Zaïr Y Marchini JS Charbonnel B Laouenan H Krempf M 《The Journal of pharmacology and experimental therapeutics》2003,306(1):332-337
Seven hypertriglyceridemic patients with type-2 diabetes were treated with atorvastatin (40 mg/day) for 2 months. Kinetics of apolipoprotein B100 (apoB100)-containing lipoproteins were determined before and after atorvastatin treatment and compared with data obtained in five normolipidemic volunteers. ApoB100 metabolism was studied using stable isotopes and multicompartmental modeling. Compared with normolipidemic obese subjects, type-2 diabetic patients had a higher apoB100 concentration in very low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), and low-density lipoproteins (LDL) (P < 0.005). Kinetic analysis showed an increase in the total apoB100 production rate (P < 0.005) related to VLDL apoB100 overproduction (P < 0.005). Patients were also characterized by a lower fractional catabolic rate (FCR) in VLDL (not significant) or IDL (P < 0.005) mainly related to a decrease in VLDL and IDL delipidation rate (P < 0.005). Catabolism of LDL was also lower in diabetic patients (P < 0.05). Atorvastatin treatment significantly decreased plasma triglycerides (P < 0.05), total and LDL cholesterol (P < 0.05), apoB100 in LDL, IDL, and VLDL (P < 0.05). Treatment significantly decreased total apoB100 production rate (P < 0.05), but only for VLDL (P < 0.05). Treatment normalized FCR in IDL and LDL (P < 0.05). We concluded that atorvastatin improved lipid abnormalities in type-2 diabetic patients not only by increasing the clearance of apoB100-containing lipoproteins but also by decreasing VLDL production. 相似文献
90.
Ying Sun Yu Lu Christopher G. Engeland Sara C. Gordon Herve Y. Sroussi 《Molecular immunology》2013,53(4):443-449
Polymorphonuclear neutrophils (PMNs) produce and release copious amounts of reactive oxygen species (ROS) which target potential bacterial invaders but also contribute to the inflammation-associated organ injuries seen in sepsis. Calprotectin is an immune regulatory protein complex made of S100A8 and S100A9 that inhibits the oxidative metabolism of PMNs in vitro, an effect that can be potentiated by the controlled activation of the protease activated receptor-2 (PAR2). The aim of this study was to test the use of a dual strategy of calprotectin and PAR2 administration to mitigate the deleterious inflammation seen in sepsis. We hypothesized that exogenous calprotectin would protect against the injuries produced by lipopolysaccharides (LPS)-induced endotoxemia and that the controlled activation of PAR2 would potentiate this beneficial effect.Exogenous S100A8 and/or a PAR2 activating peptide (PAR2 AP) were administered in a mouse model of LPS induced endotoxemia. The survival rates as well as markers of inflammation and oxidative damage were measured in the lungs, kidneys, and livers of endotoxemic mice.Mice treated with S100A8 following LPS had less PMN infiltration and less severe histological changes in their lungs, kidneys, and livers. A significantly lower score of oxidative damage in the livers and lungs of S100A8/LPS treated mice was also noted when compared to mice treated with LPS alone. This protective and anti-inflammatory effect of S100A8 was potentiated by the controlled activation of PAR2. Finally, in further support to our hypothesis, the survival rate was almost doubled from 33% to 65% and 63% in mice treated by, respectively, S100A8 and PAR2 AP, whereas 85% of the mice treated with both PAR2 AP and S100A8 survived, a statistically significant higher rate.These results support an anti-inflammatory, anti-oxidative, and protective effect of S100A8 in sepsis, and warrant further studies on the role of PAR2. 相似文献